Company Analysis

BioRestorative Therapies, Inc. (BRTX)

Nasdaq: BRTX · Services-Misc Health & Allied Services, NEC · Melville, NY · filing with the SEC since 2010
Grade3.5
◀ Past 1.9● Present 3.0▶ Future 5.6
1 est.

Who runs BioRestorative Therapies, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Alstodt Lance
President, CEO, COB. First filing Oct 2018, latest Oct 20, 2025, 33 filings in all.
Officers reporting now
2
of 7 people with a filing in the last fifteen months
Directors reporting now
5
21 people on the record since 2011
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Alstodt LancePresident, CEO, COBOct 2018Oct 20, 2025none
Silva FranciscoVP of Research and DevelopmentAug 2011Oct 20, 2025none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Randhawa EshadirectorJul 2026Jul 30, 2026none
Brown Steven CollierdirectorJul 2026Jul 24, 2026none
Dhaliwal JatinderdirectorJun 2026Jun 18, 2026none
Grasso MikadirectorJun 2026Jun 18, 2026none
Field KatharyndirectorJun 2026Jun 17, 2026none
Earlier names on the record15, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton BRTX · research, not advice